Sun et al. by immunohistochemistry reported a progressive positive rate of COX-2 from superficial gastritis, to gastric atrophy, intestinal metaplasia, dysplasia, and cancer (10.0%, 35.7%, 37.8%, 41.7%, and 69.5%, respectively) [91]. The gene discussed is PTGS2; the disease is cancer.